Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07159100 · ClinicalTrials.gov registry record · Early Phase 1
tDCS for Cancer-Related Fatigue and Weakness
A Early Phase 1 study, sponsored by Kessler Foundation.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 75
- Enrollment target
NCT07159100 is a Early Phase 1 study that has not yet begun recruiting, run by Kessler Foundation. The registered enrollment target is 75 participants.
The verdict
NCT07159100, a Early Phase 1 study, has not yet begun recruiting, sponsored by Kessler Foundation.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 75 participants
- Enrollment target
Study Summary
This pilot study investigates the effectiveness of non-invasive brain stimulation (tDCS) in alleviating cancer-related fatigue (CRF) and muscle weakness. Using a randomized, double-blind crossover design, participants perform fatiguing muscle tasks with and without tDCS, and outcomes include task endurance, maximal voluntary contraction force, and neuromuscular markers. Neural mechanisms will be assessed via EEG, TMS, and MRI.
Interventions
- DEVICE Active tDCS + elbow flexion exercise
- DRUG Sham tDCS + elbow flexion exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-09-10 |
| Est. Completion | 2027-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07159100
The ClinicalTrials.gov registry entry for NCT07159100 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active tDCS + elbow flexion exercise is the first listed.
NCT07159100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07159100 about?
NCT07159100 is a clinical study titled "tDCS for Cancer-Related Fatigue and Weakness". This pilot study investigates the effectiveness of non-invasive brain stimulation (tDCS) in alleviating cancer-related fatigue (CRF) and muscle weakness. Using a randomized, double-blind crossover design, participants perform fatiguing muscle tasks with and without tDCS, and outcomes include task en...
What is the current status of trial NCT07159100?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 75 participants. The study started on 2025-09-10. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07159100?
The interventions under investigation include: Active tDCS + elbow flexion exercise (DEVICE), Sham tDCS + elbow flexion exercise (DRUG).
Who is sponsoring clinical trial NCT07159100?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.